+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Carboxes 454248-53-4
454248-53-4,MFCD09864994
Catalog No.:AA00DLCC

454248-53-4 | tert-Butyl (r)-4-methyl-2,2-dioxo-[1,2,3]oxathiazolidine-3-carboxylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$28.00   $20.00
- +
1g
98%
in stock  
$34.00   $24.00
- +
5g
98%
in stock  
$42.00   $29.00
- +
10g
98%
in stock  
$74.00   $52.00
- +
25g
98%
in stock  
$160.00   $112.00
- +
50g
95%
in stock  
$307.00   $215.00
- +
100g
98%
in stock  
$502.00   $351.00
- +
250g
95%
in stock  
$1,063.00   $744.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00DLCC
Chemical Name:
tert-Butyl (r)-4-methyl-2,2-dioxo-[1,2,3]oxathiazolidine-3-carboxylate
CAS Number:
454248-53-4
Molecular Formula:
C8H15NO5S
Molecular Weight:
237.2734
MDL Number:
MFCD09864994
SMILES:
C[C@@H]1COS(=O)(=O)N1C(=O)OC(C)(C)C
Properties
Properties
 
Form:
Solid  
MP:
120-121℃  
Storage:
Inert atmosphere;-20 ℃;  

Computed Properties
 
Complexity:
350  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
5  
Rotatable Bond Count:
2  
XLogP3:
0.9  

Downstream Synthesis Route
t-butyl(4R)-4-methyl-1,2,3-oxathiazolidine-3-carboxylate 
  454248-53-4 

[1]Posakony,J.J.;Tewson,T.J.[Journaloflabelledcompoundsandradiopharmaceuticals,2001,vol.44,p.S925-S926]

454248-53-4   
C8H15(18)FNO5S(1-) 

[1]Posakony,J.J.;Tewson,T.J.[Journaloflabelledcompoundsandradiopharmaceuticals,2001,vol.44,p.S925-S926]

(R)-2-tertbutoxycarbonylamino-1-propanol 
  454248-53-4 

[1]Scott,JamesS.;Bailey,Andrew;Buttar,David;Carbajo,RodrigoJ.;Curwen,Jon;Davey,PaulR.J.;Davies,RobertD.M.;Degorce,SébastienL.;Donald,Craig;Gangl,Eric;Greenwood,Ryan;Groombridge,SamD.;Johnson,Tony;Lamont,Scott;Lawson,Mandy;Lister,Andrew;Morrow,ChristopherJ.;Moss,ThomasA.;Pink,JenniferH.;Polanski,Radoslaw[JournalofMedicinalChemistry,2019,vol.62,#3,p.1593-1608]

[2]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2019/245974,2019,A1Locationinpatent:Paragraph0411;0526;0527;0528

[3]Posakony,J.J.;Tewson,T.J.[Journaloflabelledcompoundsandradiopharmaceuticals,2001,vol.44,p.S925-S926]

[4]Moss,ThomasA.;Alonso,Beatriz;Fenwick,DavidR.;Dixon,DarrenJ.[AngewandteChemie-InternationalEdition,2010,vol.49,#3,p.568-571]

[5]Hebeisen,Paul;Weiss,Urs;Alker,André;Staempfli,Andreas[TetrahedronLetters,2011,vol.52,#41,p.5229-5233]

[6]Moss,ThomasA.;Barber,DavidM.;Kyle,AndrewF.;Dixon,DarrenJ.[Chemistry-AEuropeanJournal,2013,vol.19,#9,p.3071-3081]

[7]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2016/75720,2016,A1

[8]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2016/159773,2016,A1Locationinpatent:Paragraph1062-1065

[9]Haftchenary,Sina;Nelson,ShawnD.;Furst,Laura;Dandapani,Sivaraman;Ferrara,StevenJ.;Bošković,ŽarkoV.;FigueroaLazú,Samuel;Guerrero,AdrianM.;Serrano,JuanC.;Crews,DemarcusK.;Brackeen,Cristina;Mowat,Jeffrey;Brumby,Thomas;Bauser,Marcus;Schreiber,StuartL.;Phillips,AndrewJ.[ACSCombinatorialScience,2016,vol.18,#9,p.569-574]

[10]CurrentPatentAssignee:ASTRAZENECAPLC-WO2016/162325,2016,A1

[11]CurrentPatentAssignee:ASTRAZENECAPLC-WO2017/182495,2017,A1

[12]Wolfard,Jens;Xu,Jie;Zhang,Haiming;Chung,CheolK.[OrganicLetters,2018,vol.20,#17,p.5431-5434]

[13]VanZandt,MichaelC.;Jagdmann,G.Erik;Whitehouse,DarrenL.;Ji,Minkoo;Savoy,Jennifer;Potapova,Olga;Cousido-Siah,Alexandra;Mitschler,Andre;Howard,EduardoI.;Pyle,AnnaMarie;Podjarny,AlbertoD.[JournalofMedicinalChemistry,2019,vol.62,#17,p.8164-8177]

[14]Xu,Jie;Chung,CheolK.;McClory,Andrew;Mack,KyleA.;Dalziel,MichaelE.;Fettes,Alec;Clagg,Kyle;Lim,Ngiap-Kie;Wuitschik,Georg;Jenny,Christian;Finet,Laure;Kammerer,Michael;Zhang,Haiming;Angelaud,Rémy;Gosselin,Francis[OrganicProcessResearchandDevelopment,2022,vol.26,#3,p.568-582]

[15]CurrentPatentAssignee:ROCHEHOLDINGAG-US2022/2304,2022,A1

586-77-6    454248-53-4   
(2S)-1-(1S)-2-(4-N,N-dimethylamino-phenyl)-1-methyl-ethylamino-acetyl}-pyrrolidine-2-carbonitrile 

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2003/130281,2003,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 454248-53-4
1417287-40-1

1417287-40-1

 1313705-92-8

1313705-92-8

 459817-82-4

459817-82-4

 1858273-22-9

1858273-22-9

 863453-61-6

863453-61-6

 1365481-13-5

1365481-13-5
Building Blocks
More >
Tags:454248-53-4 Molecular Formula|454248-53-4 MDL|454248-53-4 SMILES|454248-53-4 tert-Butyl (r)-4-methyl-2,2-dioxo-[1,2,3]oxathiazolidine-3-carboxylate